Rheumatic heart disease
Conditions
Interventions
Training set:model training
External validation set:external validation
Sponsors
Beijing Anzhen Hospital Affiliated to Capital Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1. Age = 18 years old; 2. Clinically diagnosed as rheumatic mitral valve disease; 3. Proposed surgical treatment for rheumatic mitral valve; 4. Sign an informed consent form.
Exclusion criteria
Exclusion criteria: 1. Multiple distant metastases of tumors, with an expected lifespan of less than 1 year; 2. Patients with mental disorders who are unable to cooperate with treatment work; 3. Patients who are unable to complete follow-up; 4. Patients who did not undergo cardiac ultrasound or coronary CT examination before surgery. 5. Secondary surgery
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Short term poor surgical efficacy; | — |
Secondary
| Measure | Time frame |
|---|---|
| All cause mortality during follow-up period;Moderate or above mitral regurgitation or regurgitation during follow-up period;Valve related reoperation during follow-up period; | — |
Countries
China
Contacts
Public ContactHongjia Zhang
Beijing Anzhen Hospital
Outcome results
None listed